Gail Farfel

Gail Farfel is a seasoned biotech executive with extensive experience in leadership roles across various organizations. They have served as Chief Executive Officer at ProMIS Neurosciences, Inc. and have held significant positions such as Chief Development Officer at Zogenix, Inc. and Chief Development & Regulatory Officer at Marinus Pharmaceuticals. Currently, they are a board member at DURECT Corporation and the Dravet Syndrome Foundation, among others, while also pursuing a BA in Biochemistry at the University of Virginia. Gail earned their PhD in Neuropsychopharmacology from the University of Chicago, reinforcing their expertise in the field.